filmov
tv
GDUFA l Generic Drug User Fee Act l #regulatoryaffairs #regulators l FDA l Pharma
Показать описание
ItsMeNirupma
Рекомендации по теме
0:02:52
Part-1 GDUFA l Generic Drug User Fee Act l FDA l Regulatory Affairs l #pharmaceutical#regulations
0:05:04
GDUFA III: Facility Readiness
0:00:55
GDUFA l Generic Drug User Fee Act l #regulatoryaffairs #regulators l FDA l Pharma
0:03:12
Part-2 GDUFA lll updates l Generic Drug User Fee Act l FDA l Regulatory Affairs l #pharmaceuticals
0:00:59
GDUFA lll updates l Generic Drug User Fee Act l FDA l #pharma #regulatoryaffairs
0:20:23
Preparing for GDUFA II User Fees (6/28) Generic Drugs Forum 2017
0:08:01
GDUFA III: Controlled Correspondence
0:01:09
GDUFA I Accomplishments
0:15:13
Drug Master Files from a GDUFA II User Fee Perspective
0:23:46
GDUFA Regulatory Science Research Update (5/28) Generic Drugs Forum 2017
7:12:31
Advancing Generic Drug Development: Translating Science to Approval 2024 (Day 1)
0:11:19
GDUFA III MCRM External Training Presentation final
7:58:37
Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2
1:15:00
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 3
0:02:11
Features of GDUFA II
0:20:18
Drug Substance Quality Assessment: Best Practices (23of27) Generic Drugs Forum 2018
8:05:24
Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 1
0:22:14
Keynote: Generic Drug Program Update (1of16) Generic Drugs Forum 2020
0:08:08
ANDAs: Pre-Submission Facility Correspondence (PFC) Related to Prioritized Generic Drug Submissions
2:57:33
A Deep Dive: GDUFA III Scientific Meetings
0:03:36
Generic Drug User Fee Amendment (GDUFA) part II of II
7:01:55
Advancing Generic Drug Development: Translating Science to Approval 2024 (Day 2)
1:29:48
DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Session 4 and Closing Remarks...
1:31:24
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 2